OCULAR THERAPEUTIX INC (OCUL:NASDAQ)
$10.36 -0.46 (-4.2514%)
Analysed OCULAR THERAPEUTIX INC (OCUL:NASDAQ) News Sources
Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA Alignment
23-07-2026
marketbeat.com
Is Ocular Therapeutix (OCUL) Still Undervalued Or Is AXPAXLI Hope Already Priced In?
24-07-2026
yahoo.com
Ocular Therapeutix (OCUL) Reports Q2 Loss, Beats Revenue Estimates
03-08-2026
yahoo.com
OCUL Stock In Spotlight After Q2 Loss Comes In Narrower Than Estimated – A Look At Key Highlights
03-08-2026
stocktwits.com
Ocular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says
04-08-2026
yahoo.com
OCUL, FDMT Stock Clock Best Day In Weeks After EyePoint’s Trial Setback — Here’s Why
17-08-2026
stocktwits.com
Pharmaceuticals Stocks Q2 Highlights: Ocular Therapeutix (NASDAQ:OCUL)
21-08-2026
yahoo.com
Ocular Therapeutix (OCUL) Stock Fair Value Edges Higher After Analyst Target Increases
22-08-2026
yahoo.com
Ocular Therapeutix (OCUL) Could Be 59% Undervalued Following Earnings Beat And AXPAXLI Progress
22-08-2026
yahoo.com
Why Ocular Therapeutix (OCUL) Is Up 10.4% After Q2 Beat And AXPAXLI Phase 3 Timeline Update
22-08-2026
yahoo.com
What is the current price of OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The current price of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is $10.36.
OCULAR THERAPEUTIX INC (OCUL:NASDAQ) absolute price change since previous trading day?
The absolute price change of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) since the previous trading day is $-0.46.
OCULAR THERAPEUTIX INC (OCUL:NASDAQ) percentage price change since previous trading day?
The percentage price change of OCULAR THERAPEUTIX INC (OCUL:NASDAQ) since the previous trading day is -4.2514%.
What is the most recent average sentiment score for OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The most recent average sentiment score for OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is 54 out of 100.
What is the most recent average sentiment for OCULAR THERAPEUTIX INC (OCUL:NASDAQ)?
The most recent sentiment for OCULAR THERAPEUTIX INC (OCUL:NASDAQ) is .
SEC-8K** Filing Available For OCULAR THERAPEUTIX INC (OCUL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.